Inhibition of telomerase activity by a distamycin derivative: Effects on cell proliferation and induction of apoptosis in human cancer cells

European Journal of Cancer

Volumn 38, Issue 13, 2002, Pages 1792-1801

  Zaffaroni, N ^a   Lualdi, S ^a   Villa, R ^a   Bellarosa, D ^b   Cermele, C ^b   Felicetti, P ^b   Rossi, C ^b   Orlandi, L ^a   Daidone, M G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Menarini Ricerche SpA   (Italy)

Author keywords

Apoptosis; Distamycin derivative; Melanoma; Non small cell lung carcinoma; Osteogenic sarcoma; Telomerase; Telomere

Indexed keywords

DISTAMYCIN A; MEN 10716; POLYMYXIN; PROTEIN P16; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; TELOMERASE;

APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; EVALUATION; HUMAN; HUMAN CELL; IC 50; MELANOMA CELL; PRIORITY JOURNAL; TELOMERE; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; DRUG ANTAGONISM; ENZYMOLOGY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MELANOMA; OSTEOSARCOMA;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; DISTAMYCINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; LUNG NEOPLASMS; MELANOMA; OSTEOSARCOMA; SUPPORT, NON-U.S. GOV'T; TELOMERASE; TUMOR CELLS, CULTURED; HUMANS;

EID: 0036024592     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00139-9     Document Type: Article

References (52)

1. Structure and function of telomeres
2. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
3. Creation of human tumour cells with defined genetic elements
4. A survey of telomerase activity in human cancer
5. Telomerase inhibitors: Targeting the vulnerable end of cancer?
6. Human telomerase contains evolutionarily conserved catalytic and structural subunits
7. The RNA component of human telomerase
8. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo
9. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides
10. Inhibition of human telomerase by 2′-O-methyl-RNA
11. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
12. Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells
13. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas
14. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells
15. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells
16. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase
17. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalised human cell lines
18. Transplacental effects of 3′-azido-2′,3′-dideoxythyymidine (AZT): Tumorigenicity in mice and genotoxicity in mice and monkeys
19. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine
20. Inhibition of telomerase limits the growth of human cancer cells
21. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones
22. Quadruplex-interactive agents as telomerase inhibitors: Synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase
23. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes
24. Inhibition of telomerase activity by cisplatin in human testicular cancer cells
25. Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro
26. FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis
27. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins
28. A highly selective telomerase inhibitor limiting human cancer cell proliferation
29. Biological activity and DNA sequence specificity of synthetic carbamoyl analogues of distamycin
30. Established melanoma cell lines from different metastatic nodules of a single patient
31. Telomerase activity in benign and malignant breast lesions: A pilot prospective study on fine-needle aspirates
32. Specific association of human telomerase activity with immortal cells and cancer
33. Increased expression of protein kinase C alpha plays a key role in retinoic acid-induced melanoma differentiation
34. Effect of hyperthermia on CHO DNA polymerases alpha and beta
35. Effects of liposome-entrapped annamycin in human breast cancer cells: Interference with cell cycle progression and induction of apoptosis
36. Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: Correlation with sensitivity to DNA damaging agents
37. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus
38. Antitumor polycyclic acridines. 8.(1) synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts
39. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts
40. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes
41. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
42. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
43. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability
44. The role of senescence and immortalization in carcinogenesis
45. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
46. Coexistence od alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells
47. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
48. Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation
49. Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA
50. Treatment of prostate cancer in vitro and in vivo with 2-5-anti-telomerase RNA component
51. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells
52. Telomere states and cell fates